Free Trial
→ Washington Is Broke—and Eyeing Your Savings Next (From Priority Gold) (Ad)
OTCMKTS:GTHP

Guided Therapeutics 5/15/2025 Earnings Report

Guided Therapeutics logo
$0.13 0.00 (0.00%)
As of 05/20/2025 03:59 PM Eastern
Earnings History

Guided Therapeutics EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Guided Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Guided Therapeutics Announcement Details

Quarter
Date
5/15/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Guided Therapeutics Earnings Headlines

Guided Therapeutics (OTCMKTS:GTHP) Trading 38.9% Higher - What's Next?
May 17, 2025 | americanbankingnews.com
HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
May 10, 2025 | morningstar.com
Washington Is Broke—and Eyeing Your Savings Next
Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.
May 21, 2025 | Priority Gold (Ad)
Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China
October 22, 2024 | finance.yahoo.com
Guided therapeutics director buys shares worth $150,000
October 4, 2024 | investing.com
Guided Therapeutics Inc (GTHP)
August 21, 2024 | investing.com
See More Guided Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Guided Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Guided Therapeutics and other key companies, straight to your email.

About Guided Therapeutics

Guided Therapeutics (OTCMKTS:GTHP), a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

View Guided Therapeutics Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles